HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
BF-200 ALA
Description
BF-200 ALA is under investigation by Biofrontera which shows positive results from its Phase IIb/III trial. According to Biofrontera, BF-200 ALA was strongly and significantly superior to placebo in the treatment of actinic keratosis.
No brand information found.
